Fenugreek for Period Cramps: The Dose and Evidence Behind the Claim

A placebo-controlled fenugreek study tested seed powder during two menstrual cycles. Its capsule schedule and selected student population matter when judging a claim about cramp relief.¹

What the 2014 trial actually tested

The study enrolled 106 students with moderate-to-severe primary period pain; 101 were analyzed. Participants took two or three 900 mg seed-powder capsules three times daily for the first three menstrual days, or matching starch capsules, across two cycles.¹

Second-cycle pain scores on a 0-to-10 scale averaged 3.25 with fenugreek and 5.96 with placebo. Participants could use NSAID painkillers as needed.¹

Students with endometriosis, irregular cycles and several medical conditions were excluded. The findings cannot establish treatment for pain caused by endometriosis. Shahid Beheshti University and Zardband supported the study.¹

What the mefenamic-acid comparison showed

A separate 2016 open-label trial² enrolled 60 patients in three groups of 20: fenugreek alone, fenugreek plus dry cupping, or mefenamic acid. The published abstract describes 3 g seed powder twice daily on menstrual days 1–3, with treatment across three cycles.²

Lower-abdominal pain fell by 66.89% with fenugreek alone and 62.88% with mefenamic acid. Those are reductions within each group. The abstract supplies no confidence interval establishing that the treatments are equivalent. With no placebo group and participants aware of treatment, these percentages cannot establish how much improvement fenugreek itself caused.²

The later review still judged the effect uncertain

The 2024 systematic review included four articles, searched through February 2023. Its abstract reports a pooled benefit over placebo, but rates the evidence low quality and concludes that the effect on menstrual pain is highly uncertain.³

Its mefenamic-acid comparison found no significant difference: standardized mean difference 0.05, 95% CI −0.57 to 0.67. That interval allows differences favoring either treatment. A nonsignificant result does not establish equal effectiveness. Standardized units also cannot be read as points on a 0-to-10 pain scale.³

Food use does not settle supplement safety

The US NCCIH also describes the evidence for menstrual cramps as uncertain. It lists diarrhea, nausea, potentially harmful blood-sugar drops with large doses and allergic reactions, including serious reactions.⁴

It warns against amounts greater than those found in food during pregnancy and says safety of those amounts during breastfeeding is poorly understood. It advises discussing fenugreek with a health professional if you take medicines.⁴

Bring the product label and your usual pain-treatment list to that discussion. Record the days of pain, its severity and any medicine used, so a change in symptoms can be assessed alongside other treatment.

Chapter 7’s “What the Trials Support” in Period, Handled compares the evidence for established cramp treatments. The book’s Period Scorecard helps organize the pain history for an appointment.